Can a Second Review Change Your Prostate Cancer Grade?

Yes, a second review of your biopsy slides by an expert genitourinary pathologist (a doctor who specializes in diagnosing diseases of the urinary tract and male reproductive organs) can change your Gleason score, Grade Group, and potentially your treatment plan. Prostate cancer grading involves looking at the structural patterns of cells under a microscope, which can be subjective. An expert review can either confirm your initial diagnosis or reveal differences that might shift your risk classification ^[1][2].

Understanding the Grading System

To understand why a review matters, it helps to understand the terminology:

• Gleason Score: Pathologists grade the two most common patterns of cancer cells from 1 to 5. A score of 3+3=6 means only the less aggressive pattern 3 is present. A score of 3+4=7 means mostly pattern 3, with a smaller amount of the more aggressive pattern 4.
• Grade Group (GG): This is a newer 1-to-5 scale. Gleason 3+3=6 is Grade Group 1. Gleason 3+4=7 is Grade Group 2.
• Active Surveillance: A management plan involving careful monitoring (regular PSA tests, MRIs, and biopsies) rather than immediate surgery or radiation, typically used for low-risk prostate cancer.
• Definitive Treatment: Interventions aimed at curing the cancer, such as surgical removal of the prostate (prostatectomy) or radiation therapy.

Why Pathology Interpretations Can Differ

The most common area of disagreement involves the boundary between Gleason pattern 3 and pattern 4. While some patterns are distinct, distinguishing between them can be challenging when the tumor glands are poorly formed, fused together, or distorted by crush artifact during the biopsy procedure ^[1][3].

Additionally, agreement between pathologists is sometimes lower when a small amount of pattern 4 cancer is scattered sparsely among pattern 3 glands ^[4]. Because the difference between Grade Group 1 and Grade Group 2 is a major dividing line in risk assessment, this specific distinction is where a second opinion often matters most.

Looking Beyond the Score: High-Risk Features

An expert review is also about identifying specific, high-risk architectural patterns that may have been missed or not explicitly reported. Two key findings are:

• Invasive Cribriform Pattern: This describes cancer cells that grow in a “Swiss cheese” pattern. Under International Society of Urological Pathology (ISUP) consensus, invasive cribriform glands are always classified as Gleason pattern 4 ^[1]. However, cribriform pattern 4 is associated with a worse prognosis than other types of pattern 4 growth ^[5][6].
• Intraductal Carcinoma of the Prostate (IDC-P): This occurs when cancer cells grow inside the pre-existing, normal ducts of the prostate. IDC-P is reported separately and is not assigned a Gleason grade or Grade Group of its own, but it is strongly associated with aggressive, high-grade cancer ^[1][7].

Expert consensus statements recommend that pathologists explicitly state whether cribriform glands and IDC-P are present or absent ^[8][9]. Finding either of these features on a biopsy generally makes a patient a poor candidate for routine active surveillance, even if the overall Grade Group appears low ^[10][11]. Furthermore, if isolated IDC-P is found without invasive cancer, it commonly prompts doctors to consider an immediate repeat biopsy, as unsampled high-grade invasive cancer is likely present nearby ^[12][11].

When to Consider a Second Review

A second opinion is especially useful in the following situations:

• The diagnosis is borderline: If your report mentions “atypical glands,” “poorly formed glands,” or a very small amount of scattered pattern 4, an expert review can help clarify the findings ^[1][4].
• Your report lacks detail: If your initial pathology report does not specifically mention the percentage of pattern 4 disease or the presence/absence of cribriform pattern and IDC-P, an expert review can provide this critical missing information ^[9][8].
• You are considering active surveillance: If you have Grade Group 1 or favorable Grade Group 2 disease, confirming the exact grade and the absence of high-risk features helps ensure surveillance is a safe option ^[13][10].

What a Second Review CANNOT Do: Fix Sampling Error

If your clinical picture doesn’t match the biopsy (for example, if your PSA density—your PSA level divided by your prostate volume—is very high, or your MRI shows a highly suspicious lesion, but your biopsy only shows low-grade cancer), a second slide review may not be the solution. A pathologist can only review the tissue that was actually captured by the biopsy needles. If the needles missed a higher-grade tumor, a slide review will not find it ^[14][15]. In cases of clinical discordance, you may need a repeat targeted biopsy rather than just a slide review ^[16].

How a Revised Report Impacts Treatment

Changes to your pathology report can alter your eligibility for different treatments, but it is rarely an automatic decision:

• Upgrading: If a review upgrades your cancer to Grade Group 2, this does not automatically mean you need surgery or radiation. While higher grades increase the recommendation for definitive treatment, selected men with low-volume Grade Group 2 disease (Gleason 3+4), a low percentage of pattern 4, and no cribriform/IDC-P features may still choose active surveillance ^[13][17].
• Adverse Features: If the review identifies invasive cribriform pattern or IDC-P, active surveillance is typically no longer recommended due to a higher risk of the cancer progressing ^[10].
• Downgrading: What was initially thought to be a small amount of pattern 4 might be reinterpreted as pattern 3 (Grade Group 1), which could make you a stronger candidate for active surveillance ^[2].

Remember that your pathology grade should always be considered alongside your PSA levels, MRI findings, the number of positive cores, and the amount of tumor found in the biopsy ^[17][18].

How Slides Are Transferred

The actual biopsy tissue is processed into thin slices mounted on glass microscopic slides, and the remaining tissue is preserved in wax blocks ^[19]. You don’t need another biopsy procedure for a second pathology opinion.

Instead, your urologist’s office or you can contact the original pathology laboratory and request that your materials be sent directly to a specialized laboratory or a genitourinary pathologist. Be prepared to ask about logistics:

• Requirements: Some labs require written authorization to release materials.
• Materials: The reviewing lab may request the glass slides, unstained slides, or the paraffin wax blocks themselves.
• Costs and Timing: Check if your insurance covers the review, if there are out-of-pocket fees, and what the expected turnaround time is so it does not inappropriately delay your care.